Innovation Management
Innovation Management at a Glance
Innovation is part of MEGA’s business, sustainability and operating culture. The Company identifies Innovation Management as a Governance Dimension material topic and connects innovation with product development, digital health, operational efficiency, environmental improvement and customer value.
- Innovation Management
- MEGA commitment
- Branded products sales presence
- Mega We Care™ branded products revenue
- Product development
- Product categories
- Total registrations worldwide
- Total registrations outside Thailand
- Registrations in Thailand
- Unique products
- Digital health applications
- Digital health users enrolled
Challenges and Opportunities
Healthcare needs are changing across developing and underdeveloped markets.
Consumers are becoming more health-conscious, chronic diseases are increasing, healthcare professionals expect science-led product information, and customers want products that are reliable, affordable and supported by responsible service.
For MEGA, innovation must respond to these needs without compromising quality or trust. New products require careful product development, regulatory review, quality assurance, responsible product information and market understanding. Digital health solutions also need to be practical, accessible and supported by data protection and responsible use.
The opportunity is to make innovation useful and disciplined. MEGA can strengthen its product pipeline, develop products in categories where the Company has market knowledge and brand credibility, use digital health tools to support access, and connect product innovation with product stewardship and customer satisfaction.
Healthcare needs are evolving across developing markets.
Strengthen product development in categories where MEGA understands customer, consumer and healthcare needs.
New products must meet quality, safety and regulatory expectations.
Connect product innovation with Regulatory Affairs, quality assurance, GMP compliance and product registration.
Customers and healthcare professionals expect accurate and responsible product information.
Strengthen product information, responsible communication, labelling control and Marketing Code of Conduct practices.
Consumers need more support to manage health proactively.
Develop digital health applications and health knowledge platforms that support preventive and curative care.
Product innovation can create intellectual property, data and cyber risks.
Protect product knowledge, personal data, digital platforms and proprietary information.
Customer expectations differ across countries and channels.
Use market understanding, customer engagement and feedback systems to improve product relevance and service.
Why Innovation Management Matters to MEGA
MEGA’s purpose is to help people stay healthy as long as they live. Innovation matters because health needs do not remain the same. Consumers age, lifestyles change, chronic diseases increase, customer expectations evolve, and markets become more competitive.
Innovation also matters because MEGA’s growth depends on staying relevant in fast-growing healthcare markets. Product innovation helps MEGA strengthen its portfolio, enter high-opportunity segments, respond to customer and consumer needs, and maintain trust through quality and responsible product information
For MEGA, innovation management must therefore balance creativity with discipline. A new product, digital tool or health solution must create value, but it must also meet quality expectations, comply with regulatory requirements, protect data, respect intellectual property and support responsible use.
Our Innovation Management Approach
MEGA’s innovation approach begins with continuous improvement. We encourage people to question outdated methods, seek better solutions and find new approaches that help build a better MEGA. This reflects the MEGA Way and the Company’s commitment to provide quality products and services through constant improvement and innovation.
In practice, innovation is guided by product relevance and responsible execution. Product ideas must be connected to real health needs, customer expectations, market opportunity and MEGA’s capability to deliver quality products. Once an opportunity is identified, innovation must be supported by product development discipline, regulatory review, quality systems, responsible product information and customer feedback.
This keeps innovation close to MEGA’s purpose. We do not treat innovation as a separate activity. It is part of how we develop products, serve customers, support consumers, protect trust and make health solutions more accessible.
Product and Portfolio Innovation
Product innovation at MEGA is connected to the needs of customers, consumers, patients and healthcare professionals. The Mega We Care™ branded products business develops, manufactures, markets and sells nutraceutical products, complementary medicines, prescription pharmaceuticals and OTC health products.
MEGA’s growth is supported by a strong product pipeline driven by an efficient and targeted product development strategy. This helps the Company strengthen and expand its portfolio in fast-growing healthcare markets where MEGA has brand credibility, market knowledge and the ability to compete effectively.
Product and portfolio innovation also support healthcare access. By focusing on quality products that fit people’s needs and by operating in developing and underdeveloped markets, MEGA connects innovation with affordability, availability and the Company’s long-term commitment to Human Wellness.
Product Development, Registration and Regulatory Capability
Product innovation in healthcare requires more than ideas. It requires regulatory capability, technical knowledge and disciplined product registration. MEGA’s Regulatory Affairs team comprises more than 150 people worldwide with technical qualifications, including Ph.D. level.
The team conducts dossier preparation for self-formulated and self-manufactured products, dossier audits for third-party sourcing, and product registration applications across more than 34 countries. As of 31 December 2025, MEGA had 4,405 total registrations worldwide, including 3,002 registrations outside Thailand and 1,403 registrations in Thailand. MEGA also had 1,438 unique products across nutraceutical, OTC and prescription categories.
Product Stewardship and Quality Discipline
Product innovation must be supported by product responsibility. MEGA’s product responsibility and responsible business practices are part of the backbone of the Company’s existence and are material concerns for the Board of Directors, Executives and Management.
MEGA follows strict compliance with regulatory standards, including current Good Manufacturing Practices of respective markets, EU GMP standards, Australian GMP standards and specific requirements of regulators worldwide. The Company follows a risk-based approach for quality assurance and a robust quality control process after manufacturing, including testing samples and storing samples.
Responsible Product Innovation Controls
| Control Area | Role in Product Innovation |
|---|---|
| Regulatory Standards | Ensure products meet market requirements |
| GMP Compliance | Support manufacturing quality and consistency |
| Quality Assurance | Apply risk-based controls and process discipline |
| Quality Control | Test and verify product quality after manufacturing |
| Packaging and Labelling Controls | Reduce risk of mislabeling, inadequate information or product misuse |
Customer Insight and Feedback for Product Relevance
Innovation must stay close to customers. MEGA’s customer relationship management activities include understanding management’s customer proposition, educating customers on products and MEGA’s facilities, improving awareness of consumers’ health conditions, and building awareness within MEGA about customers’ business propositions and challenges.
Customer satisfaction surveys also help MEGA listen and learn. For Maxxcare, customer satisfaction is collected through a Customer Satisfaction Survey Form, with collection directly done by Delivery Man and summary and analysis by the Customer Care Team. In 2025, the survey covered 212 customers, with 200 completed surveys and 12 refusals.
Responsible Product Information, Marketing and Labelling
Product innovation must be supported by responsible communication. MEGA’s Marketing Code of Conduct provides guidance on interactions with healthcare professionals, promotional aids, medical utility items, samples, patient organizations, patient education and support, medical representatives, promotional materials, product-related claims, off-label claims, symposia and congresses.
This matters because product innovation can only create trust when product information is accurate, compliant and not misleading. MEGA manages risks related to product claims, labelling, product information and customer communication through regulatory review, quality controls, responsible marketing guidance and pharmacovigilance procedures.
| Control Area | Role in Product Innovation |
|---|---|
| Marketing Code of Conduct | Guides responsible healthcare professional and customer engagement |
| Product Claims Control | Supports responsible and compliant product-related communication |
| Product Information and Labelling | Helps customers and consumers understand product use and safety information |
| Pharmacovigilance | Provides channels for product-related safety feedback |
| Regulatory Review | Supports alignment with market requirements |
Intellectual Property, Data Protection and Product Trust
Product innovation creates knowledge. This makes intellectual property, data protection and cyber security important parts of responsible innovation management.
MEGA identifies Intellectual Property Protection and Cyber Security as Governance Dimension material topics. These topics are relevant to product innovation because product knowledge, digital health systems, customer information, employee data, supplier information and business data are increasingly connected.
MEGA’s approach to responsible product innovation therefore includes compliance with intellectual property laws, protection of Company intellectual property, data protection, cyber risk assessment and protection against cyber attacks. These controls help ensure that innovation creates value without creating unnecessary risk.
Disclosed Target / Management Focus
MEGA’s innovation management focus areas are connected to product relevance, product development, regulatory capability, customer feedback, product stewardship, digital health and responsible controls.
Continue strengthening the product pipeline through efficient and targeted product development.
Continue developing products and services that fit customer and consumer needs.
Continue supporting product registration through Regulatory Affairs, dossier preparation and regulatory review.
Continue embedding quality, safety, product information and responsible use into product innovation.
Continue improving digital health solutions that support preventive and curative aspects of care.
Continue using customer engagement and feedback to improve product relevance and service quality.
Continue applying the Marketing Code of Conduct, product claims controls, product information and labelling discipline.
Continue maintaining channels for consumers and healthcare professionals to report product-related safety information.
Continue protecting product knowledge, Company intellectual property, digital systems and personal data.
